K. Patel

Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.

A. Goy, Takemi Tanaka, A. Pecora, 2018, Breast.

The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses

N. Schultz, K. Iczkowski, H. Rui, 2023, Research square.

The G protein coupled receptor CCR5 in cancer.

A. Kossenkov, R. Pestell, X. Jiao, 2020, Advances in cancer research.

Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer

T. Golub, Chao Cheng, E. Demidenko, 2018, The Journal of experimental medicine.

The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses

N. Schultz, K. Iczkowski, H. Rui, 2023, Oncogene.

Abstract PD4-08: A microenvironment secretome screen reveals FGF2 as a mediator of resistance to anti-estrogens and PI3K/mTOR pathway inhibitors in ER+ breast cancer

T. Golub, Chao Cheng, E. Demidenko, 2018 .